Jin-Jer Chen

2.0k total citations
53 papers, 1.7k citations indexed

About

Jin-Jer Chen is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Jin-Jer Chen has authored 53 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 18 papers in Molecular Biology and 12 papers in Physiology. Recurrent topics in Jin-Jer Chen's work include Nitric Oxide and Endothelin Effects (10 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (5 papers). Jin-Jer Chen is often cited by papers focused on Nitric Oxide and Endothelin Effects (10 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (5 papers). Jin-Jer Chen collaborates with scholars based in Taiwan, United States and Canada. Jin-Jer Chen's co-authors include Tzu‐Hurng Cheng, Ju‐Chi Liu, Neng‐Lang Shih, Teng‐Nan Lin, Jui‐Sheng Wu, Cheng‐Hsien Chen, Heng Lin, Juey‐Jen Hwang, Paul Chan and Fu‐Tien Chiang and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Jin-Jer Chen

52 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jin-Jer Chen Taiwan 23 675 617 287 236 175 53 1.7k
Francesca Seta United States 26 548 0.8× 497 0.8× 318 1.1× 193 0.8× 184 1.1× 48 1.8k
Weimin Li China 24 683 1.0× 930 1.5× 139 0.5× 265 1.1× 238 1.4× 134 2.1k
Keiichiro Kataoka Japan 28 689 1.0× 665 1.1× 432 1.5× 224 0.9× 161 0.9× 45 2.1k
Yoshiko Tokutomi Japan 21 487 0.7× 488 0.8× 392 1.4× 279 1.2× 132 0.8× 34 1.6k
Suresh S. Palaniyandi United States 27 661 1.0× 500 0.8× 257 0.9× 149 0.6× 219 1.3× 56 1.6k
Sharon Williams‐Ignarro Italy 19 427 0.6× 281 0.5× 327 1.1× 209 0.9× 183 1.0× 22 1.6k
Alexander Akhmedov Switzerland 25 686 1.0× 480 0.8× 307 1.1× 400 1.7× 472 2.7× 49 2.0k
Hideharu Tomita Japan 17 520 0.8× 825 1.3× 436 1.5× 221 0.9× 124 0.7× 26 1.5k
Vasundhara Kain United States 28 771 1.1× 698 1.1× 378 1.3× 315 1.3× 340 1.9× 63 2.1k
Kou‐Gi Shyu Taiwan 30 850 1.3× 904 1.5× 162 0.6× 517 2.2× 106 0.6× 65 2.3k

Countries citing papers authored by Jin-Jer Chen

Since Specialization
Citations

This map shows the geographic impact of Jin-Jer Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin-Jer Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin-Jer Chen more than expected).

Fields of papers citing papers by Jin-Jer Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin-Jer Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin-Jer Chen. The network helps show where Jin-Jer Chen may publish in the future.

Co-authorship network of co-authors of Jin-Jer Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jin-Jer Chen. A scholar is included among the top collaborators of Jin-Jer Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin-Jer Chen. Jin-Jer Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chao, Hung‐Hsing, Po‐Yuan Chen, Tzu‐Hurng Cheng, et al.. (2017). Lipopolysaccharide pretreatment increases protease-activated receptor-2 expression and monocyte chemoattractant protein-1 secretion in vascular endothelial cells. Journal of Biomedical Science. 24(1). 85–85. 18 indexed citations
2.
Lian, Wei‐Shiung, et al.. (2015). The Prostaglandin Agonist Beraprost Aggravates Doxorubicin-mediated Apoptosis by Increasing iNOS Expression in Cardiomyocytes. Current Vascular Pharmacology. 13(1). 54–63. 3 indexed citations
3.
Chen, Yu‐Chang, Jui‐Sheng Wu, Chien‐Yu Huang, et al.. (2012). Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) and Neurodegenerative Disorders. Molecular Neurobiology. 46(1). 114–124. 105 indexed citations
4.
Wu, Cho‐Kai, Jen-Kuang Lee, Fu‐Tien Chiang, et al.. (2011). Plasma levels of tumor necrosis factor-α and interleukin-6 are associated with diastolic heart failure through downregulation of sarcoplasmic reticulum Ca2+ ATPase. Critical Care Medicine. 39(5). 984–992. 109 indexed citations
5.
Chao, Hung‐Hsing, Hong-Jye Hong, Li‐Chin Sung, et al.. (2011). Nicorandil attenuates cyclic strain-induced endothelin-1 expression via the induction of activating transcription factor 3 in human umbilical vein endothelial cells. European Journal of Pharmacology. 667(1-3). 292–297. 8 indexed citations
6.
Dai, Dao‐Fu, Peterus Thajeb, Cheng-Fen Tu, et al.. (2008). Plasma Concentration of SCUBE1, a Novel Platelet Protein, Is Elevated in Patients With Acute Coronary Syndrome and Ischemic Stroke. Journal of the American College of Cardiology. 51(22). 2173–2180. 92 indexed citations
7.
Chen, Yen‐Ling, Ju‐Chi Liu, Shih‐Hurng Loh, et al.. (2008). Involvement of reactive oxygen species in urotensin II-induced proliferation of cardiac fibroblasts. European Journal of Pharmacology. 593(1-3). 24–29. 29 indexed citations
8.
Cheng, Tzu‐Hurng, Neng‐Lang Shih, Jia‐Wei Lin, et al.. (2005). Nitric Oxide Inhibits Endothelin-1-Induced Cardiomyocyte Hypertrophy through cGMP-mediated Suppression of Extracellular-Signal Regulated Kinase Phosphorylation. Molecular Pharmacology. 68(4). 1183–1192. 28 indexed citations
10.
Cheng, Tzu‐Hurng, Ju‐Chi Liu, Heng Lin, et al.. (2004). Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy. Naunyn-Schmiedeberg s Archives of Pharmacology. 369(2). 239–244. 40 indexed citations
11.
Cheng, Tzu‐Hurng, et al.. (2003). Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. Journal of the American College of Cardiology. 42(10). 1845–1854. 127 indexed citations
12.
Tsai, Chien‐Sung, Tzu‐Hurng Cheng, Cheng‐I Lin, et al.. (2001). Inhibitory effect of endothelin-1 on the isoproterenol-induced chloride current in human cardiac myocytes. European Journal of Pharmacology. 424(2). 97–105. 4 indexed citations
14.
Shyu, Kou‐Gi, et al.. (1995). Diagnostic Accuracy of Transesophageal Echocardiography for Detecting Patent Ductus Arteriosus in Adolescents and Adults. CHEST Journal. 108(5). 1201–1205. 22 indexed citations
15.
Hwang, Juey‐Jen, Yi‐Heng Li, Yu‐Lin Ko, et al.. (1994). Left Atrial Appendage Function Determined by Transesophageal Echocardiography in Patients with Rheumatic Mitral Valve Disease. Cardiology. 85(2). 121–128. 23 indexed citations
16.
Shyu, Kou‐Gi, Jun-Jack Cheng, Jin-Jer Chen, et al.. (1994). Recovery of atrial function after atrial compartment operation for chronic atrial fibrillation in mitral valve disease. Journal of the American College of Cardiology. 24(2). 392–398. 60 indexed citations
17.
Hwang, Juey‐Jen, Peiliang Kuan, Jin-Jer Chen, et al.. (1994). Significance of left atrial spontaneous echo contrast in rheumatic mitral valve disease as a predictor of systemic arterial embolization: A transesophageal echocardiographic study. American Heart Journal. 127(4). 880–885. 25 indexed citations
19.
Hwang, Juey‐Jen, et al.. (1993). Traumatic Rupture of the Pericardium with a Peculiar Chest Radiographic Finding. Cardiology. 83(5-6). 415–418. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026